Work

Abstract PD4-08: Real-world biomarker testing patterns in US patients with HER2-negative metastatic breast cancer

Year: 2026

Type: conference-abstract

Source: Clinical Cancer Research

DOI: 10.1158/1557-3265.sabcs25-pd4-08

Authors: S. Yadav, Q. Li, Z. Tan, K. E. Mishkin, J. F. Hayes, X. Xu, F. J. Couch

Institutions: Mayo Clinic, AstraZeneca (United States), AstraZeneca (Canada), Merck & Co., Inc., Rahway, NJ, USA (United States)

Language: English

Topic: BRCA gene mutations in cancer

Subfield: Genetics

Field: Biochemistry, Genetics and Molecular Biology

Domain: Life Sciences

SDGs: Good health and well-being, Reduced inequalities

Open Access status: closed

OpenAlex ID: W7129392101

Cites:

Cited by:

Related to: